Guillermo
Martínez de Tejada de Garaizábal
Catedrático de Universidad
University Hospital of Zurich
Zúrich, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Zurich (1)
2022
-
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial
Clinical Infectious Diseases, Vol. 75, Núm. 1, pp. E585-E593